These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15214505)

  • 1. Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle.
    Mabandla M; Kellaway L; St Clair Gibson A; Russell VA
    Metab Brain Dis; 2004 Jun; 19(1-2):43-50. PubMed ID: 15214505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
    Howells FM; Russell VA; Mabandla MV; Kellaway LA
    Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.
    Fine JM; Forsberg AC; Renner DB; Faltesek KA; Mohan KG; Wong JC; Arneson LC; Crow JM; Frey WH; Hanson LR
    Brain Res; 2014 Jul; 1574():96-104. PubMed ID: 24928620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
    O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
    Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
    Bagga V; Dunnett SB; Fricker RA
    Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
    Mabandla MV; Nyoka M; Daniels WM
    Brain Res; 2015 Oct; 1622():64-71. PubMed ID: 26111646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats.
    Mabandla MV; Russell VA
    Behav Brain Res; 2010 Jul; 211(1):16-22. PubMed ID: 20206210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C; Kirik D; Björklund A; Cenci MA
    Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
    Sharma S; Taliyan R; Singh S
    Behav Brain Res; 2015 Sep; 291():306-314. PubMed ID: 26048426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions.
    Chang JW; Wachtel SR; Young D; Kang UJ
    Neuroscience; 1999 Jan; 88(2):617-28. PubMed ID: 10197780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia.
    Rentsch P; Stayte S; Morris GP; Vissel B
    BMC Neurosci; 2019 Feb; 20(1):5. PubMed ID: 30760214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats.
    Fang C; Yin J; Xu Z; Wang Y; Xu H; Zhou H; Gao C
    Cell Biochem Biophys; 2011 Jan; 59(1):49-56. PubMed ID: 20714825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model.
    Landers MR; Kinney JW; van Breukelen F
    Brain Res; 2014 Jan; 1543():263-70. PubMed ID: 24239657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in rats using a lateralised nose-poking task with low stimulus-response compatibility.
    Dowd E; Dunnett SB
    Behav Brain Res; 2005 Dec; 165(2):181-6. PubMed ID: 16139374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
    Lin L; Yan M; Wu B; Lin R; Zheng Z
    Brain Res Bull; 2018 Sep; 142():338-343. PubMed ID: 30172737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.